CervoMed Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	9.44	9	7.79	4.09	6.67
Short-Term Investments	17.86	29.92	-	-	-
Cash & Short-Term Investments	27.29	38.92	7.79	4.09	6.67
Cash Growth	-41.50%	399.46%	90.37%	-38.59%	-
Accounts Receivable	1.36	2.25	0.92	-	-
Other Receivables	-	-	-	-	0.07
Receivables	1.36	2.25	0.92	-	0.07
Prepaid Expenses	1.69	1.91	1.26	0.06	0.02
Other Current Assets	0.27	-	-	-	0.05
Total Current Assets	30.61	43.08	9.96	4.16	6.82
Other Long-Term Assets	-	-	0.01	-	-
Total Assets	30.61	43.08	9.97	4.16	6.82
Accounts Payable	1.35	1.51	0.66	0.1	0.02
Accrued Expenses	3.16	2.25	1.84	0.59	0.4
Current Portion of Long-Term Debt	-	-	-	12.41	4.11
Other Current Liabilities	0.09	0.12	0.09	0.05	0.03
Total Current Liabilities	4.6	3.88	2.6	13.16	4.56
Long-Term Debt	-	-	-	-	5.92
Total Liabilities	4.6	3.88	2.6	13.16	10.47
Common Stock	0.01	0.01	0.01	0	0
Additional Paid-In Capital	115.61	109.87	61.81	18.98	18.52
Retained Earnings	-89.61	-70.73	-54.44	-52.27	-46.47
Comprehensive Income & Other	0.01	0.06	-	-	-
Total Common Equity	26.01	39.2	7.38	-33.29	-27.94
Shareholders' Equity	26.01	39.2	7.38	-9	-3.66
Total Liabilities & Equity	30.61	43.08	9.97	4.16	6.82
Total Debt	-	-	-	12.41	10.03
Net Cash (Debt)	27.29	38.92	7.79	-8.32	-3.36
Net Cash Growth	-41.50%	399.46%	-	-	-
Net Cash Per Share	3.07	4.82	2.93	-16.06	-0.75
Filing Date Shares Outstanding	9.25	8.7	6.17	4.5	4.5
Total Common Shares Outstanding	9.25	8.7	5.67	4.5	4.5
Working Capital	26.01	39.2	7.37	-9	2.26
Book Value Per Share	2.81	4.50	1.30	-7.39	-6.21
Tangible Book Value	26.01	39.2	7.38	-33.29	-27.94
Tangible Book Value Per Share	2.81	4.50	1.30	-7.39	-6.21

Source: S&P Capital IQ. Standard template. Financial Sources.